• European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment 

      Zouboulis, C.C.; Bechara, F.G.; Benhadou, F.; Bettoli, V.; Bukvić Mokos, Mokos; Del Marmol, Marmol; Dolenc-Voljč, M.; Giamarellos-Bourboulis, E.J.; Grimstad, Øystein; Guillem, P.; Horváth, B.; Hunger, R.E.; Ingram, J.R.; Ioannidis, D.; Just, E.; Kemény, L.; Kirby, B.; Liakou, A.I.; McGrath, B.M.; Marzano, A.V.; Matusiak, L.; Molina-Leyva, A.; Nassif, A.; Podda, M.; Prens, E.P.; Prignano, F.; Raynal, H.; Romanelli, M.; Saunte, D.M.L.; Szegedi, A.; Szepietowski, J.C.; Tzellos, Thrasyvoulos; Valiukevičienė, S.; van der Zee, der; van Straalen, Straalen; Villumsen, B.; Jemec, G.B.E. (Journal article; Tidsskriftartikkel; Peer reviewed, 2024-12-19)
      Introduction: This second part of the S2k guidelines is an update of the 2015 S1 European guidelines.<p> <p>Objective: These guidelines aim to provide an accepted decision aid for the selection, implementation and assessment of appropriate and sufficient therapy for patients with hidradenitis suppurativa/acne inversa (HS). <p>Methods: The chapters have been selected after a Delphi procedure among ...